Jinyu Bio-technology Co., Ltd. (SHA:600201)
China flag China · Delayed Price · Currency is CNY
11.90
-0.10 (-0.83%)
Nov 17, 2026, 3:00 PM CST

Jinyu Bio-technology Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,5501,3431,2251,5081,4851,754
Other Revenue
53.7653.7630.1389.9243.9722.64
1,6041,3961,2551,5981,5291,776
Revenue Growth
20.85%11.23%-21.45%4.55%-13.94%12.29%
Cost of Revenue
738.37665.07597.17668.1697.3688.81
Gross Profit
865.4731.35658.29930.13831.371,088
Selling, General & Admin
480.21525432.34491.55421.77501.9
Research & Development
118.73131.09136.82143.47133.78165.94
Other Operating Expenses
69.8823.3621.8323.1422.2624.5
Operating Expenses
731.21727.63621.1681.43579.36693.32
Operating Income
134.23.7237.19248.7252.01394.19
Interest Expense
-1.15-0.47-5.5-0.05-4.81-0.04
Interest & Investment Income
27.8751.1755.3656.5250.9147.57
Currency Exchange Gain (Loss)
-0.43-0.430.05-0.020.08-0.05
Other Non Operating Income (Expenses)
-2.07-2.85-0.580.150.21-0.76
EBT Excluding Unusual Items
158.4151.1486.52305.28298.39440.91
Impairment of Goodwill
---3.21-18.08-65.02-39.75
Gain (Loss) on Sale of Investments
-47.88-4.01-9.49-7.78-9.81-3.22
Gain (Loss) on Sale of Assets
0.068.382.58-0.04-0.04-2.31
Asset Writedown
-10.94-2.91-11.11-5.34-1.54-1.99
Other Unusual Items
109.1152.0259.6341.7823.6119.65
Pretax Income
208.76104.62124.91315.83245.58413.27
Income Tax Expense
32.669.1120.7638.7345.4624.27
Earnings From Continuing Operations
176.195.51104.15277.1200.12389.01
Minority Interest in Earnings
-11.384.614.836.5310.54-6.72
Net Income
164.72100.11108.99283.63210.66382.29
Net Income to Common
164.72100.11108.99283.63210.66382.29
Net Income Growth
63.48%-8.14%-61.58%34.64%-44.90%-5.89%
Shares Outstanding (Basic)
1,1131,1121,0901,0911,1091,124
Shares Outstanding (Diluted)
1,1131,1121,0901,0911,1091,124
Shares Change
6.10%2.06%-0.10%-1.61%-1.39%-0.35%
EPS (Basic)
0.150.090.100.260.190.34
EPS (Diluted)
0.150.090.100.260.190.34
EPS Growth
54.09%-10.00%-61.54%36.84%-44.12%-5.56%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
215.34194.69199.89141.67154.54160.4
Free Cash Flow Per Share
0.190.170.180.130.140.14
Dividend Per Share
0.0370.0370.0300.0800.0600.110
Dividend Growth
23.33%23.33%-62.50%33.33%-45.45%-8.33%
Gross Margin
53.96%52.37%52.43%58.20%54.38%61.22%
Operating Margin
8.37%0.27%2.96%15.56%16.49%22.19%
Profit Margin
10.27%7.17%8.68%17.75%13.78%21.52%
Free Cash Flow Margin
13.43%13.94%15.92%8.86%10.11%9.03%
EBITDA
413.28255.42252.37437.17450.92585.17
EBITDA Margin
25.77%18.29%20.10%27.35%29.50%32.94%
D&A For EBITDA
279.08251.7215.18188.47198.91190.98
EBIT
134.23.7237.19248.7252.01394.19
EBIT Margin
8.37%0.27%2.96%15.56%16.48%22.19%
Effective Tax Rate
15.64%8.71%16.62%12.26%18.51%5.87%
Revenue as Reported
1,6041,3961,2551,5981,5291,776
Advertising Expenses
-205.95162.42179.06166.38241.94